Our results regarding global downregulation of SOCS2 in tumoral samples compared with ANCTs are in line with Farabegoli et al. study which demonstrated a role for SOCS2 downregulation in the enhancement of cell proliferation and tumor growth in breast cancer [14]. The gene discussed is SOCS2; the disease is neoplasm.